The FDA has released draft guidance related to the safety of ai medical devices. This move is seen as an opportunity for stakeholders to provide input on the regulation of ai in medical devices, with potential implications for businesses and healthcare. The specifics of the guidance and its potential impact are still being discussed and clarified, with the FDA seeking feedback on certain aspects of device classification.